References
- MacLachlan JH, Cowie BC. Hepatitis B virus epidemiology. Cold Spring Harb Perspect Med. 2015;5(5):a021410.
- da Saúde M. Boletim Epidemiológico de Hepatites Virais. Secretaria de Vigilância em Saúde - Departamento de DST. Aids e Hepatites Virais 2012;17:8.
- Allain J-P, Stramer SL, Carneiro-Proietti ABF, et al. Transfusion-transmitted infectious diseases. Biologicals 2009;37(2):71.
- Candotti D, Laperche S. Hepatitis B virus blood screening: need for reappraisal of blood safety measures? Front Med (Lausanne). 2018;5:29.
- Ferreira CT, Silveira TR. Hepatites virais: aspectos da epidemiologia e da prevenção. Rev Bras Epidemiol. 2004;7(4):473–487. Available in: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-790X2004000400010.
- Bruce MG, Bruden D, Hurlburt D, et al. Antibody levels and protection after hepatitis B vaccine: results of a 30-year follow-up study and response to a booster dose. J Infect Dis. 2016;214(1):16–22.
- Hammitt LL, Hennessy TW, Fiore AE, et al. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years. Vaccine 2007;25:6958–6964.
- Apiung T, Ndanu TA, Mingle JAA, Sagoe WC. Hepatitis B virus surface antigen and antibody markers in children at a major paediatric hospital after the pentavalent DTP-HBV-Hib vaccination. Ghana Med J. 2017;51(1):13–19.
- Ministério da Saúde, Secretaria de Vigilância em Saúde, Departamento de Vigilância das Doenças Transmissíveis. Manual de Normas e Procedimentos Para Vacinação. Brasília, DF: Ministério da Saúde; 2014.
- Pereira LM, Martelli CM, Merchán-Hamann E, et al. Population-based multicentric survey of hepatitis B infection and risk factor differences among three regions in Brazil. Am J Trop Med Hyg. 2009;81(2):240–247.
- Yusuf HR, Daniels D, Smith P, Coronado V, Rodewald L. Association between administration of hepatitis B vaccine at birth and completion of the hepatitis B and 4:3:1:3 vaccine series. JAMA 2000;284(8):978–983.
- Mahoney FJ. Update on diagnosis, management, and prevention of hepatitis b virus infection. Clin Microbiol Rev. 1999;12(2):351–366.
- Dia.Pro Diagnostic BioProbes s.rl. Hepatitis B. https://www.diapro.it/index.php/products/elisa/hepatitis/hepatitis-b. Accessed October 21, 2018.
- Moraes JC, Luna EJA, Grimaldi RA. Immunogenicity of the Brazilian hepatitis B vaccine in adults. Rev Saude Publica. 2010;44(2):353–359.
- Mast EE, Margolis HS, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep. 2005;54(RR-16):1–31.
- Elghannam DM, Aly RM, Goda EF, Eltoraby EE, Farag RE. Clinical significance of antibody to hepatitis B core antigen in multitransfused hemodialysis patients. Asian J Transfus Sci. 2009;3(1):14–17.
- Costa NCPD, Canhestro MR, Soares CMBM, Rodrigues JS. Monitoring of post-vaccination anti-HBs titles vaccine in children and adolescents in the pre-dialysis of chronic kidney disease. J Bras Nefrol. 2017;39(3):296–304.
- Petersen KM, Bulkow LR, McMahon BJ, et al. Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth. Pediatr Infect Dis J. 2004;23(7):650–655.